January 03, 2025
1 min read
Cencora completed its acquisition of Retina Consultants of America, according to a press release.
At closing, Cencora’s cash outlay was $4.4 billion, including transaction fees and expenses, the repayment of debt and the equity rollover with Retina Consultants of America (RCA), an amount which is subject to post-closing purchase price adjustment. The company updated its adjusted diluted earnings per share guidance range for fiscal year 2025 to a range of $15.15 to $15.45.
Cencora acquired an interest of approximately 85% in RCA.
“The acquisition allows Cencora to build on its leadership in specialty, expand its [management services organization] solutions and drive differentiated value for stakeholders, including physicians and patients,” the company said in the release.
Leave a Reply